MLI Form 4: EVP/CFO Sells 66,029 Shares at $95.61 Avg
Mueller Industries insider sale reported on Form 4: Martin Jeffrey Andrew, EVP, CFO & Treasurer, sold 66,029 shares of Mueller Industries, Inc. (MLI) on 08/29/2025.
Rhea-AI Filing Summary
Mueller Industries insider sale reported on Form 4: Martin Jeffrey Andrew, EVP, CFO & Treasurer, sold 66,029 shares of Mueller Industries, Inc. (MLI) on 08/29/2025. The sale was executed pursuant to a previously disclosed Rule 10b5-1 trading plan and reported at a weighted-average price of $95.6054, with individual trade prices ranging from $95.24 to $96.54. After the reported sale, the reporting person beneficially owned 305,358 shares. The Form 4 was signed by an attorney-in-fact on 09/02/2025. All information is taken directly from the filed Form 4 and reflects a planned disposition under an established trading arrangement.
Positive
- Transaction executed under a disclosed Rule 10b5-1 plan, indicating pre-planned trading and reduced concerns about opportunistic timing
- Weighted-average sale price disclosed ($95.6054) and explicit price range ($95.24–$96.54), providing price transparency
- Post-transaction beneficial ownership reported (305,358 shares), clarifying current holdings
Negative
- Insider sold 66,029 shares, a sizable absolute number that may be material to some investors' perception
- Form 4 shows sale code S (disposition) which reduces insider shareholdings without accompanying contextual company information in this filing
Insights
TL;DR: Routine, pre-planned insider sale under a 10b5-1 plan; disclosed volume and weighted-average price provided.
The reported transaction is a sale of 66,029 shares executed under a previously disclosed Rule 10b5-1 trading plan, minimizing implication of opportunistic timing. The filing discloses a weighted-average sale price of $95.6054 and a price range of $95.24–$96.54. Post-transaction beneficial ownership is stated as 305,358 shares. From a market-impact perspective, this is a clear, procedural disclosure rather than a company performance signal; the 10b5-1 plan designation indicates the trades were pre-authorized.
TL;DR: Compliance-focused disclosure; use of an attorney-in-fact and 10b5-1 plan indicates formal governance processes.
The Form 4 shows adherence to insider trading disclosure rules, including explicit notation that transactions were effected pursuant to a Rule 10b5-1 plan and a signed submission by an attorney-in-fact. This supports transparency in executive trading activity. The filing does not indicate any amendment or additional disclosures beyond the sale and resulting beneficial ownership balance.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 66,029 | $95.6054 | $6.31M |
Footnotes (2)
- F1. This form reflects the sale of shares which may be deemed to be beneficially owned by the Reporting Person. The sale was effected pursuant to a previously disclosed Rule 10b5-1 trading plan.
- F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.24 to $96.54, inclusive.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Mueller Industries insider Jeffrey Martin sell according to the Form 4?
Who filed or signed the Form 4?
What is the reporting person’s role at Mueller Industries?
AI-generated analysis. How Rhea-AI works. Not financial advice.